inositol has been researched along with Local Neoplasm Recurrence in 2 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A supplementation with Boswellia, betaine and myo-inositol reduces fibroadenoma dimension in young women." | 9.22 | A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas. ( Alwasel, SH; Bizzarri, M; Cucina, A; Dinicola, S; Giuliani, A; Harrath, AH; Pasta, V; Tartaglia, F, 2016) |
| "A supplementation with Boswellia, betaine and myo-inositol reduces fibroadenoma dimension in young women." | 5.22 | A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas. ( Alwasel, SH; Bizzarri, M; Cucina, A; Dinicola, S; Giuliani, A; Harrath, AH; Pasta, V; Tartaglia, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Abtah, ME | 1 |
| Wenke, MR | 1 |
| Talati, P | 1 |
| Fu, M | 1 |
| Kim, D | 1 |
| Weerasekera, A | 1 |
| He, J | 1 |
| Vaynrub, A | 1 |
| Vangel, M | 1 |
| Rapalino, O | 1 |
| Andronesi, O | 1 |
| Arrillaga-Romany, I | 1 |
| Forst, DA | 1 |
| Yen, YF | 1 |
| Rosen, B | 1 |
| Batchelor, TT | 1 |
| Gonzalez, RG | 1 |
| Dietrich, J | 1 |
| Gerstner, ER | 1 |
| Ratai, EM | 1 |
| Pasta, V | 1 |
| Dinicola, S | 1 |
| Giuliani, A | 1 |
| Harrath, AH | 1 |
| Alwasel, SH | 1 |
| Tartaglia, F | 1 |
| Cucina, A | 1 |
| Bizzarri, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI[NCT02843230] | 30 participants (Actual) | Observational | 2016-08-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for inositol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
A randomized trial of Boswellia in association with betaine and myo-inositol in the management of breast fibroadenomas.
Topics: Adult; Betaine; Boswellia; Breast Neoplasms; Female; Fibroadenoma; Humans; Inositol; Neoplasm Recurr | 2016 |
1 other study available for inositol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma.
Topics: Angiogenesis Inhibitors; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Female; Glioblastoma; Huma | 2022 |